ABSTRACT
This paper considers the theoretical predictions of the effects of cross-border pharmaceutical trade on the pricing decisions of multinational pharmaceutical manufacturers and the effects of these pricing decisions on the profits of the multinational pharmaceutical manufacturers, research and development activities, and social welfare.